Mutual of America Capital Management LLC Makes New $13.85 Million Investment in Stevanato Group S.p.A. (NYSE:STVN)

Mutual of America Capital Management LLC acquired a new position in shares of Stevanato Group S.p.A. (NYSE:STVN) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 635,531 shares of the company’s stock, valued at approximately $13,848,000. Mutual of America Capital Management LLC owned about 0.21% of Stevanato Group as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Van Berkom & Associates Inc. acquired a new stake in Stevanato Group during the fourth quarter worth approximately $39,000. Hardy Reed LLC lifted its position in Stevanato Group by 8.2% during the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after acquiring an additional 840 shares during the last quarter. Lindenwold Advisors INC lifted its position in Stevanato Group by 13.5% during the third quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock worth $239,000 after acquiring an additional 1,415 shares during the last quarter. Raymond James Trust N.A. lifted its position in Stevanato Group by 22.6% during the third quarter. Raymond James Trust N.A. now owns 12,556 shares of the company’s stock worth $251,000 after acquiring an additional 2,317 shares during the last quarter. Finally, Captrust Financial Advisors lifted its position in Stevanato Group by 12.7% during the third quarter. Captrust Financial Advisors now owns 13,100 shares of the company’s stock worth $262,000 after acquiring an additional 1,480 shares during the last quarter.

Analyst Ratings Changes

A number of research firms have recently weighed in on STVN. Wolfe Research began coverage on shares of Stevanato Group in a research report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target for the company. Bank of America lifted their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, December 13th. Finally, Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 price target (down from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Stevanato Group has a consensus rating of “Moderate Buy” and an average target price of €28.60 ($29.79).

Stevanato Group Stock Performance

Shares of NYSE:STVN opened at €18.44 ($19.21) on Friday. The company’s 50 day simple moving average is €21.54 and its 200 day simple moving average is €20.54. The stock has a market capitalization of $5.58 billion, a price-to-earnings ratio of 39.23, a price-to-earnings-growth ratio of 7.18 and a beta of 0.56. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. Stevanato Group S.p.A. has a 1 year low of €16.56 ($17.25) and a 1 year high of €34.00 ($35.42).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.